Fibrate and Statin Synergistically Increase the Transcriptional Activities of PPARα/RXRα and Decrease the Transactivation of NFκB
- 11 January 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 290 (1), 131-139
- https://doi.org/10.1006/bbrc.2001.6141
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-IJournal of Clinical Investigation, 2001
- Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cellsLife Sciences, 2000
- Activation of PPARδ alters lipid metabolism in db/db miceFEBS Letters, 2000
- Farnesol Stimulates Differentiation in Epidermal Keratinocytes via PPARαJournal of Biological Chemistry, 2000
- Statin + fibrate combination therapy: Fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular diseaseInternational Journal of Cardiology, 1999
- Bezafibrate has an antioxidant effect: Peroxisome proliferator-activated receptor α is associated with Cu2+, Zn2+-superoxide dismutase in the liverLife Sciences, 1998
- SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein.Genes & Development, 1996
- The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990